Skip to main content
. 2017 Oct 2;130(19):2064–2072. doi: 10.1182/blood-2017-06-743252

Figure 3.

Figure 3.

Schema of activated kinase signaling in Ph-like ALL. Kinase fusions and other alterations in Ph-like ALL activate oncogenic signal transduction and may be targetable by specific kinase inhibitors and other therapeutic agents.